PIVOTAL TRIAL DESIGN
Optimising Phase II and Phase III trial design to meet Global regulatory and HTA requirements
MODEL VALIDATION AND DATA INPUT
Ensuring structural validity of cost effectiveness and budget impact models to communicate clinical and economic value
REAL WORLD EVIDENCE STRATEGY
Building a robust demonstration of real world outcomes to support pre and post launch market access strategy